"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Alivus Life Sciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : HIREN KARSANBHAI PATEL
Home : Indian Private	Book Value: 245.7876662
BSE Code : 543322	Market Cap: 10594.76
NSE Code : ALIVUS	P / E : 19.98

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	672.89	587.98	601.85	649.55
Other Income	13.93	14.72	8.99	10.09
Total Income	686.82	602.70	610.83	659.63
Total Expenditure	467.27	408.81	429.54	451.11
Operating Profit	219.54	193.89	181.30	208.52
Interest	1.49	1.32	1.25	1.26
Gross Profit	218.05	192.57	180.05	207.26
Depreciation	19.66	18.44	17.06	15.97
Tax	53.92	39.95	38.94	47.88
Deferred Tax	-5.79	4.16	2.51	1.55
Reported Profit After Tax	150.26	130.03	121.54	141.87

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView